PRINCIPAL FINANCIAL GROUP INC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 167 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$131,693
+2.1%
121,938
+22.0%
0.00%
Q2 2023$128,968
-15.0%
99,976
-13.0%
0.00%
Q1 2023$151,749
-23.7%
114,962
-13.3%
0.00%
Q4 2022$198,851
+275.2%
132,567
+195.0%
0.00%
Q3 2022$53,000
+1.9%
44,943
-2.6%
0.00%
Q2 2022$52,000
-65.8%
46,140
-8.9%
0.00%
Q1 2022$152,000
+16.0%
50,639
+2.3%
0.00%
Q4 2021$131,000
-48.0%
49,509
-28.7%
0.00%
Q3 2021$252,000
-12.5%
69,397
+4.6%
0.00%
Q2 2021$288,000
+12.9%
66,328
-11.2%
0.00%
Q1 2021$255,000
-6.6%
74,691
-4.1%
0.00%
Q4 2020$273,000
-47.9%
77,919
-64.3%
0.00%
Q3 2020$524,000
+94.8%
218,290
+48.2%
0.00%
Q2 2020$269,000
+263.5%
147,317
+211.3%
0.00%
Q1 2020$74,000
-27.5%
47,324
-1.1%
0.00%
Q4 2019$102,000
+7.4%
47,828
-5.6%
0.00%
Q3 2019$95,000
-20.2%
50,650
+10.9%
0.00%
Q2 2019$119,000
-1.7%
45,688
-3.1%
0.00%
Q1 2019$121,000
+11.0%
47,173
-0.2%
0.00%
Q4 2018$109,000
-35.1%
47,272
-9.7%
0.00%
Q3 2018$168,000
+29.2%
52,347
+14.2%
0.00%
Q2 2018$130,000
+80.6%
45,847
+124.9%
0.00%
Q1 2018$72,000
-2.7%
20,381
+6.3%
0.00%
Q4 2017$74,000
+51.0%
19,1810.0%0.00%
Q3 2017$49,000
-21.0%
19,181
-15.2%
0.00%
Q2 2017$62,000
-13.9%
22,626
+4.1%
0.00%
Q1 2017$72,000
+67.4%
21,743
+20.2%
0.00%
Q4 2016$43,000
-29.5%
18,084
+8.9%
0.00%
Q3 2016$61,000
+64.9%
16,6010.0%0.00%
Q2 2016$37,000
+19.4%
16,601
+10.8%
0.00%
Q1 2016$31,000
-31.1%
14,9780.0%0.00%
Q4 2015$45,000
+21.6%
14,9780.0%0.00%
Q3 2015$37,000
-51.3%
14,978
-37.1%
0.00%
Q2 2015$76,000
+33.3%
23,831
-19.0%
0.00%
Q3 2014$57,000
-57.5%
29,411
-26.7%
0.00%
Q2 2013$134,00040,1070.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders